ArticleOncotarget2016

Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.

Laudine Communal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.